Modulation of uptake of organic cationic drugs in cultured human colon adenocarcinoma Caco-2 cells by an ecto-alkaline phosphatase activity

Journal of Cellular Biochemistry

Volumn 87, Issue 4, 2002, Pages 408-416

  Calhau, C ^a,b   Martel, F ^a   Hipolito Reis C ^a   Azevedo, I ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

1 methyl 4 phenylpyridinium (MPP+); Caco 2 cells; Ecto alkaline phosphatase; Uptake

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 4 NITROPHENYLPHOSPHATASE; ALKALINE PHOSPHATASE; ASCORBIC ACID; GENISTEIN; ISOBUTYLMETHYLXANTHINE; OKADAIC ACID; ORGANIC COMPOUND; ORTHOVANADIC ACID; PHOSPHATASE; RETINOIC ACID; VERAPAMIL; ANTIOXIDANT; CATION; VANADIC ACID;

APICAL MEMBRANE; ARTICLE; CATION TRANSPORT; CELL MEMBRANE; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONTROLLED STUDY; DEPHOSPHORYLATION; DRUG UPTAKE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ADENOCARCINOMA; CELL CULTURE; COLON TUMOR; DOSE RESPONSE; ENZYMOLOGY; METABOLISM; PROTEIN TRANSPORT; UPREGULATION;

ADENOCARCINOMA; ALKALINE PHOSPHATASE; ANTIOXIDANTS; ASCORBIC ACID; CACO-2 CELLS; CATIONS; CELL MEMBRANE; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN TRANSPORT; TRETINOIN; TUMOR CELLS, CULTURED; UP-REGULATION; VANADATES;

EID: 0036031925     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10306     Document Type: Article

References (56)

1. Anagnostou F, Plas C, Forest N. 1996. Ecto-alkaline phosphatase considered as levamisole-sensitive phosphohydrolase at physiological pH range during mineralization in cultured fetal calvaria cells. J Cell Biochem 60:484-494.
2. Artursson P. 1991. Cell cultures as models for drug absorption across the intestinal mucosa. Crit Rev Ther Drug Carrier Syst 8:305-330.
3. Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal (Caco-2) cells. Biochem. Biophys Res Commun 175:880-885.
4. Basson MD, Emenaker NJ, Rashid Z. 1998. Effects of modulation of tyrosine phosphorylation on brush border enzyme activity in human Caco-2 intestinal epithelial cells. Cell Tissue Res 292(3):553-562.
5. Bradford MM. 1976. A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
6. Calhau C, Hipólito-Reis C, Azevedo I. 1999. Alkaline phosphatase and exchange surfaces. Clin Biochem 32:153-154.
7. Calhau C, Martel F, Hipólito-Reis C, Azevedo I. 2000a. Effect of p-glycoprotein modulators on alkaline phosphatase activity in cultured rat hepatocytes. Cell Physiol Biochem 10:177-186.
8. Calhau C, Martel F, Hipólito-Reis C, Azevedo I. 2000b. Differences between duodenal and jejunal rat alkaline phosphatase. Clin Biochem 33:571-577.
9. Calhau C, Martel F, Pinheiro-Silva S, Pinheiro H, Soaresda-Silva P, Hipólito-Reis C, Azevedo I. 2002a. Modulation of insulin transport in rat brain microvessel endothelial cells by an ecto-phosphatase activity. J Cell Biochem 84:389-400.
10. - transport by phosphorylation dephosphorylation pathways in RBE4 cells: Role of ecto-alkaline phosphatase. Naunyn-Schmiedeberg's Arch Pharmacol 365(5):349-356.
11. Chan JRA, Stinson RA. 1986. Dephosphorylation of phosphoproteins of human liver plasma membranes by endogenous and purified liver alkaline phosphatases. J Biol Chem 261:7635-7639.
12. Charbonneau H, Tonks NK. 1992. 1002 Protein phosphatases? Annu Rev Cell Biol 8:463-493.
13. Delie F, Rubas W. 1997. A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Crit Rev Therap Drug Carrier Systems 14:221-286.
14. DePierre JW, Karnovsky ML. 1974. Ecto-enzymes of the guinea pig polymorphonuclear leucocyte I. Evidence for an ecto-adenosine monophosphatase-adenosine triphosphatase, and ap-nitrophenyl phosphatase. J Biol Chem 249:7111-7120.
15. El Hafny B, Bourre JM, Roux F. 1996. Synergistic of gamma-glutamyl transpeptidase and alkaline phosphatase activities by retinoic acid and astroglial factors in immortalized rat brain microvessel endothelial cells. J Cell Physiol 167:451-460.
16. Hardman J, Limbird L, Molinoff P, Ruddon R, Gilman A. 1996. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill.
17. Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterisation of the human colonic carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterol 96:736-749.
18. Hohage H, Lelleck S, Stachon A, Haxelmans S, Koepsell H, Schlatter E. 1998. Activation by forskolin of the organic cation transporter rOCT1 expressed in HEK293 cells. Naunyn-Schmiedeberg's Arch Pharmacol 358(Suppl. 2): R741.
19. Hooijberg JH, Broxterman HJ, Heijn M, Fles DL, Lankelma J, Pinedo HM. 1997. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 413:344-348.
20. Javitch JA, D'Amato RJ, Strittmatter SM, Snyder SH. 1985. Parkinsonism-inducing neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: Uptake of the metabolite N-methyl-4-phenylpyridinium by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173-2177.
21. Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. 1998. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J Biol Chem 273:15971-15979.
22. Koepsell H. 1998. Organic cation transporters in intestine, kidney, liver, and brain. Ann Rev Physiol 60:243-267.
23. + exchanger of renal brush-border membrane vesicles. Am J Physiol 258:F597-F605.
24. Lemmens R, Vanduffel L, Teuchy H, Culic O. 1996. Regulation of proliferation of LLC-MK2 cells by nucleosides and nucleotides: The role of ecto-enzymes. Biochem J 316:551-557.
25. Lennernas H. 1997. Human jejunal effective permeability and its correlation with preclinical drug absorption models. J Pharm Pharmacol 49:627-638.
26. 3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: Putative involvement of a p-glycoprotein transporter. Br J Pharmacol 119:1519-1524.
27. + in freshly isolated rat hepatocytes: Evidence for interaction with catecholamines. Naunyn-Schmiedeberg's Arch Pharmacol 354:305-311.
28. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H, Schömig E. 1996c. Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1. Naunyn-Schmiedeberg's Arch Pharmacol 354:320-326.
29. Martel F, Calhau C, Hipólito-Reis C. 1998a. Effect of bile duct obstruction on hepatic uptake of 1-methyl-4-phenylpyridinium in the rat. Pharmacol Res 37:497-504.
30. Martel F, Martins MJ, Calhau C, Hipólito-Reis C, Azevedo I. 1998b. Postnatal development of organic cation transport in the rat liver. Pharmacol Res 37:131-136.
31. Martel F, Ribeiro L, Calhau C, Azevedo I. 1999. Comparison between uptake2 and rOCT1: Effects of catecholamines, metanephrines, and corticosterone. Naunyn-Schmiedeberg's Arch Pharmacol 359:303-309.
32. + in human intestinal epithelial (Caco-2) cells. Naunyn-Schmiedeberg's Arch Pharmacol 361:505-513.
33. Martel F, Gründemann D, Calhau C, Schömig E. 2001a. Apical uptake of organic cations by human intestinal Caco-2 cells: Putative involvement of ASF transporters. Naunyn-Schmiedeberg's Arch Pharmacol 363:40-49.
34. - transport by phosphorylation/dephosphorylation pathways in RBE4 cells: Role of ecto-alkaline phosphatase. Naunyn-Schmiedeberg's Arch Pharmacol 365(5):349-356.
35. McComb RB, Bowers GN, Posen J, Posen S. 1979. Alkaline Phosphatase. New York: Plenum.
36. Mehrens T, Lelleck S, Cetinkaya I, Knollmann M, Hohage H, Gorboulev V, Boknik P, Koepsell H, Schlatter E. 2000. The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. J Am Soc Nephrol 11:1216-1224.
37. Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A. 1985. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Eur J Pharmacol 116:179-181.
38. Morton DJ, Barrett-Connor EL, Schneider DL. 2001. Vitamin C supplement use and bone mineral density in postmenopausal women. J Bone Miner Res 16(1):135-140.
39. Ohkubo S, Kimura J, Matsuoka I. 2000. Ecto-alkaline phosphatase in NG108-15 cells: A key enzyme mediating P1 antagonist-sensitive ATP response. Br J Pharmacol 131(8):1667-1672.
40. Redegeld FA, Caldwell CC, Sitkovsky MV. 1999. Ectoprotein kinases: Ecto-domain phosphorylation as a novel target for pharmacological manipulation? TIPS 20(11):453-459.
41. +). Naunyn-Schmiedeberg's Arch Pharmacol 346:158-165.
42. Russ H, Staudt K, Martel F, Gliese M, Schömig E. 1996. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur J Neurosci 8:1256-1264.
43. Said HM, Ortiz A, Kumar CK, Chatterjee N, Dudeja PK, Rubin S. 1999. Transport of thiamine in human intestine: Mechanism and regulation in intestinal epithelial cell model Caco-2. Am J Physiol 277 (Cell Physiol 46):C645-C651.
44. Sayre LM. 1989. Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Toxicol Lett 48:121-149.
45. Scheibe RJ, Kuehl H, Krautwald S, Meissner JD, Mueller WH. 2000. Ecto-alkaline phosphatase activity identified at physiological pH range on intact P19 and HL-60 cells is induced by retinoic acid. J Cell Physiol 76:420-436.
46. Seargeant LE, Stinson RA. 1979. Inhibition of human alkaline phosphatase by vanadate. Biochem J 181;247:250.
47. Sjoden G, Rosenqvist M, Kriegholm E, Nordenstrom J, Bjorkhem I. 1990. Verapamil increases serum alkaline phosphatase in hypertensive patients. J Intern Med 228:339-342.
48. Sokol PP, Holohan PD, Ross CR. 1987. The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles. J Pharmacol Exp Ther 242:152-157.
49. Streich S, Brüss M, Bönisch H. 1996. Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn-Schmiedeberg's Arch Pharmacol 353:328-333.
50. Sugimoto E, Yamaguchi M. 2000. Anabolic effect of genistein in osteoblastic MC3T3-E1 cells. Int J Mol Med 5(5):515-520.
51. Swarup G, Cohen S, Garbers DL. 1981. Selective dephosphorylation of proteins containing phosphotyrosine by alkaline phosphatase. J Biol Chem 256:8197-8201.
52. Vollmayer P, Koch M, Braun N, Heine P, Servos J, Israr E, Kegel B, Zimmermann H. 2001. Multiple ecto-nucleotidases in PC12 cells: Identification and cellular distribution after heterologous expression. J Neurochem 78:1019-1028.
53. Whyte MP, Mahuren JD, Fedde KN, Cole FS, McCabe ER, Coburn SP. 1988. Perinatal hypophosphatasia: Tissue levels of vitamin B6 are unremarkable despite markedly increased circulating concentrations of pyridoxal-5′-phosphate. Evidence for an ectoenzyme role for tissue-nonspecific alkaline phosphatase. J Clin Invest 81(4):1234-1239.
54. Yamagiwa H, Endo N, Tokunaga K, Hayami T, Hatano H, Takahashi HE. 2001. In vivo bone-forming capacity of human bone marrow-derived stromal cells is stimulated by recombinant human bone morphogenetic protein-2. J Bone Miner Metab 19(1):20-28.
55. Yee S. 1997. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth. Pharmacol Res 14:763-766.
56. Zhang L, Brett CM, Giacomini KM. 1998. Role of organic cation transporters in drug absorption and elimination. Ann Rev Pharmacol Toxicol 38:431-460.